Multi-indication label expansion: Semaglutide approved across obesity, cardiovascular risk reduction, MASH, and sleep apnea creates a total addressable patient population of approximately 640 million globally nearly four times the obesity-only base adding new prescriber populations including cardiologists, hepatologists, and sleep medicine specialists
At Contour Medical Spa, our team offers a compounded version of Tirzepatide tailored to meet your specific needs for optimal results
Youll repeat this process routinely where youll meet with our physician assistants to check your progress and determine if an increase in your dosage is appropriate
[PMID: 17701096] PubMed record related to this compound for laboratory literature review
doi: 10.3390/ijms21155342
Government-insurance patients are generally excluded from manufacturer cards, so third-party coupons can matter more in those cases